Find clinical trials for Breast Cancer in Austin, TX
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Austin, TX, USA:
standard dose of Cap alone in patients with advanced or metastatic breast cancer. The goal of the study is to assess the efficacy a ...
Phase 2
Austin, Texas, United States and 12 other locations
Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...
Phase 3
New Braunfels, Texas, United States and 78 other locations
of sapanisertib and serabelisib (PIKTOR) with fulvestrant and/or other anticancer therapies in participants with HR+/HER2- advanced/metastatic breast...
Phase 1, Phase 2
Austin, Texas, United States and 6 other locations
growth factor receptor (HER)2-low, hormone receptor (HR) positive breast cancer patients whose disease has progressed on endocrine ...
Phase 3
Austin, Texas, United States and 292 other locations
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer...
Phase 3
Austin, Texas, United States and 805 other locations
treatment of HR-positive, HER2-negative advanced or metastatic breast cancer.HR-positive breast cancer cells have...
Phase 3
Austin, Texas, United States and 205 other locations
endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast...
Phase 3
New Braunfels, Texas, United States and 566 other locations
ribociclib or abemaciclib with letrozole) in people with breast cancer:* HR-positive (breast cancer cells that ne...
Phase 3
Round Rock, Texas, United States and 462 other locations
ovarian function in premenopausal women with HR+, HER2-negative breast cancer and men with HR+ breast cancer. The...
Phase 3
Austin, Texas, United States and 48 other locations
adjuvant endocrine therapy for patients with ER+/HER2- early breast cancer with intermediate-high or high risk for disease recurren...
Phase 3
Austin, Texas, United States and 660 other locations
Clinical trials
Research sites
Resources
Legal